A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
FIGS, Inc.
FIGS
$1.7B
Mkt Cap
$9.51
+2.92%
FIGS, Inc. (FIGS) has a current P/E ratio of 50.1, compared to its historical median P/E of 61.4. The stock is currently considered Cheap based on its historical valuation range.
FIGS, Inc. (FIGS) has a 5-year average return on invested capital (ROIC) of 23.4%. This indicates strong capital allocation and a potential competitive advantage.
FIGS, Inc. (FIGS) has a market capitalization of $1.9B. It is classified as a small-cap stock.
FIGS, Inc. (FIGS) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.47%.
Based on historical P/E analysis, FIGS, Inc. (FIGS) appears cheap. The current P/E of 50.1 is 19% below its historical median of 61.4. The estimated fair value CAGR (P/E method) is 1.1%.
FIGS, Inc. (FIGS) operates in the Apparel & Other Finishd Prods Of Fabrics & Similar Matl industry, within the Consumer Cyclical sector.
FIGS, Inc. (FIGS) reported annual revenue of $631 million in its most recent fiscal year, based on SEC EDGAR filings.
Our mission is to celebrate, empower and serve those who serve others. We are a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. We are committed to helping this growing, global community of professionals, whom we refer to as Awesome Humans, look, feel and perform at their best—24/7, 365 days a year. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function and style, all at an affordable price. In doing so, we have redefined what scrubs are—giving rise to our tag-line: why wear scrubs, when you can #wearFIGS? By elevating scrubs and creating premium products for healthcare professionals that support them on and off-shift, we revolutionized the large and fragmented healthcare apparel market, branded a previously unbranded industry and de-commoditized a previously commoditized product.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 666M | 631M | 556M | 546M | 506M | 420M |
| Net Income | 41M | 34M | 2.7M | 23M | 21M | -9.6M |
| EPS | $0.23 | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 |
| Free Cash Flow | 39M | 53M | 64M | 85M | -41M | 64M |
| ROIC | 30.2% | 22.1% | 1.7% | 38.9% | 39.5% | 14.7% |
| Gross Margin | 66.6% | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% |
| Debt/Equity | 0.00 | 0.14 | 0.14 | 0.13 | 0.06 | 0.27 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 43M | 38M | 2.3M | 34M | 38M | 11M |
| Operating Margin | 6.4% | 6.0% | 0.4% | 6.2% | 7.4% | 2.6% |
| ROE | 9.4% | 8.4% | 0.7% | 6.6% | 7.7% | -5.6% |
| Shares Outstanding | 196M | 180M | 136M | 189M | 193M | 159M |
| Metric | ||||||||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 110M | 263M | 420M | 506M | 546M | 556M | 631M | 666M |
| Gross Margin | 71.8% | 72.3% | 71.8% | 70.1% | 69.1% | 67.6% | 66.5% | 66.6% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 22M | 42M | 150M | 121M | 141M | 143M | 143M | 147M |
| EBIT | -347K | 58M | 11M | 38M | 34M | 2.3M | 38M | 43M |
| Op. Margin | -0.3% | 22.0% | 2.6% | 7.4% | 6.2% | 0.4% | 6.0% | 6.4% |
| Net Income | 112K | 50M | -9.6M | 21M | 23M | 2.7M | 34M | 41M |
| Net Margin | 0.1% | 18.9% | -2.3% | 4.2% | 4.1% | 0.5% | 5.4% | 6.1% |
| Non-Recurring | -120K | -2K | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | N/A | 50.8% | 14.7% | 39.5% | 38.9% | 1.7% | 22.1% | 30.2% |
| ROE | N/A | 72.9% | -5.6% | 7.7% | 6.6% | 0.7% | 8.4% | 9.4% |
| ROA | N/A | 74.2% | -4.3% | 6.0% | 5.2% | 0.6% | 6.3% | 7.2% |
| Cash Flow | ||||||||
| Op. Cash Flow | 6.5M | 22M | 66M | -35M | 101M | 81M | 61M | 49M |
| Free Cash Flow | 1.8M | 19M | 64M | -41M | 85M | 64M | 53M | 39M |
| Owner Earnings | 5.9M | 12M | -16M | -75M | 52M | 32M | 25M | 13M |
| CapEx | 4.8M | 2.3M | 2.7M | 5.3M | 16M | 17M | 8.2M | 9.3M |
| Maint. CapEx | 500K | 946K | 1.4M | 1.9M | 2.9M | 6.7M | 9.0M | 10M |
| Growth CapEx | 4.3M | 1.3M | 1.3M | 3.4M | 13M | 10M | 0 | 0 |
| D&A | 500K | 946K | 1.4M | 1.9M | 2.9M | 6.7M | 9.0M | 10M |
| CapEx/OCF | N/A | N/A | 4.1% | N/A | 16.2% | 21.0% | 13.4% | 19.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 45M | 2.7M | 8.8M |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | 5.6% | 0.1% | 0.5% |
| Stock-Based Comp | 179K | 8.7M | 81M | 37M | 46M | 43M | 27M | 25M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | N/A | N/A | N/A | -244M | -317M | -226M | -285M | -319M |
| Cash & Equiv. | 38M | 58M | 195M | 160M | 144M | 86M | 82M | 319M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | 0.37 | 0.27 | 0.06 | 0.13 | 0.14 | 0.14 | 0.00 |
| Interest Coverage | -0.8 | 426.0 | 109.8 | 22.1 | 5.0 | N/A | N/A | N/A |
| Equity | N/A | 98M | 246M | 308M | 377M | 377M | 437M | 431M |
| Total Assets | N/A | 134M | 312M | 395M | 473M | 510M | 580M | 563M |
| Total Liabilities | N/A | 36M | 66M | 87M | 96M | 133M | 143M | 133M |
| Intangibles | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | 27M | 18M | 39M | 62M | 64M | 99M | 105M |
| Working Capital | N/A | 88M | 231M | 285M | 328M | 293M | 357M | 352M |
| Current Assets | 342K | 120M | 293M | 357M | 386M | 383M | 447M | 432M |
| Current Liabilities | N/A | 33M | 62M | 71M | 57M | 90M | 91M | 80M |
| Per Share Data | ||||||||
| EPS | 0.00 | 0.30 | -0.06 | 0.11 | 0.12 | 0.02 | 0.19 | 0.23 |
| Owner EPS | 0.04 | 0.07 | -0.10 | -0.39 | 0.28 | 0.23 | 0.14 | 0.07 |
| Book Value | N/A | 0.59 | 1.54 | 1.60 | 2.00 | 2.77 | 2.43 | 2.20 |
| Cash Flow/Share | 0.04 | 0.13 | 0.42 | -0.18 | 0.53 | 0.60 | 0.34 | 0.26 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 153.6M | 165.9M | 159.3M | 192.6M | 188.6M | 136.0M | 180.3M | 196.1M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | 61.2 | 61.4 | 300.5 | 62.2 | 42.1 |
| P/FCF | N/A | N/A | 64.3 | N/A | 16.4 | 12.7 | 40.2 | 47.3 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 36.1 |
| Price/Book | N/A | N/A | 16.7 | 4.2 | 3.7 | 2.2 | 4.9 | 4.3 |
| Price/Sales | N/A | N/A | 14.0 | 4.9 | 2.5 | 1.4 | 1.8 | 2.8 |
| FCF Yield | N/A | N/A | 1.6% | -3.1% | 6.1% | 7.8% | 2.5% | 2.1% |
| Market Cap | 0 | N/A | 4.1B | 1.3B | 1.4B | 817M | 2.1B | 1.9B |
| Avg. Price | 0.00 | N/A | 36.95 | 12.86 | 7.14 | 5.63 | 6.44 | 9.51 |
| Year-End Price | 0.00 | N/A | 25.71 | 6.73 | 7.37 | 6.01 | 11.81 | 9.51 |
FIGS, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
FIGS, Inc. trades at 50.1x trailing earnings, compared to its 15-year median P/E of 61.4x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 28.4x vs a median of 28.3x. The company's 5-year average ROIC is 23.4% with a gross margin of 69.0%. Total shareholder yield (buybacks) is 0.5%. At current prices, the estimated annualized return to fair value is +1.2%.
FIGS, Inc. (FIGS) has a net profit margin of 5.4%. This is a modest margin.
FIGS, Inc. (FIGS) generated $53 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
FIGS, Inc. (FIGS) has a debt-to-equity ratio of 0.14. This indicates a conservatively financed balance sheet.
FIGS, Inc. (FIGS) reported earnings per share (EPS) of $0.19 in its most recent fiscal year.
FIGS, Inc. (FIGS) has a return on equity (ROE) of 8.4%. This indicates moderate shareholder returns.
FIGS, Inc. (FIGS) has a 5-year average gross margin of 69.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 7 years of financial data for FIGS, Inc. (FIGS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
FIGS, Inc. (FIGS) has a book value per share of $2.43, based on its most recent annual SEC filing.